News

  1. Home
  2. News

Libera Bio receives the Bioga Award for the Best Biotech Business Idea 2020

Libera Bio is a spin-off of the Maria Jose Alonso’s lab at the University of Santiago de Compostela that develops anticancer drugs based on nanotechnology. The goal of its project is to address "undruggable" oncology targets by delivering whole antibodies inside the tumor and metastatic cells.

Engineering Anisotropic Meniscus: Zonal Functionality and Spatiotemporal Drug Delivery

The authors acknowledge the original source of publication. Final publication is available from Mary Ann Liebert, Inc.: http://dx.doi.org/10.1089/ten.teb.2020.0096

Get free access to our latest paper: “Laser-induced transient skin disruption to enhance cutaneous drug delivery”

Free access until November 07 to this article published in European Journal of Pharmaceutics and Biopharmaceutics.

María José Alonso receives the prestigious ‘Medal of Merit in Research and Education’ granted by the Government of Spain

María José Alonso’s lab has pioneered numerous discoveries in the field of Pharmaceutical Nanotechnology and Nanomedicine. Her research is focused on designing novel nanostructured materials intended to transport drugs and antigens across biological barriers and deliver them to the target tissue, with the final goal of producing innovative nanomedicines and vaccines

Our latest paper, published in Frontiers in Immunology: “Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors”

Publication: Dacoba TG, Anfray C, Mainini F, Allavena P, Alonso MJ, Torres Andón F and Crecente-Campo J (2020) Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors. Front. Immunol. 11:1412. doi: 10.3389/fimmu.2020.01412

María José Alonso receives the prestigious ‘Distinguished Service Award’ and the ‘Women in Science Award’ of Controlled Release Society (CRS)

These are new recognitions of the outstanding career of Professor Alonso by international scientific institutions, after her election to the US National Academy of Medicine, to the prestigious College of Fellows of the American Institute for Medical and Biological Engineering’s (AIMBE) and to the CRS College of Fellows. Alonso also received the “CRS Founders Award” granted by this scientific organization in 2018

Polyaminoacid-based nanocarriers: a review of the latest candidates for oral drug delivery

In this review, we present an update of the current approaches and strategies carried out in the design of nanosystems and penetration-enhancing oral delivery strategies based on polyaminoacids.

María José Alonso, elected Secretary of the Controlled Release Society

María José Alonso leads a USC project aimed at developing a new vaccine against COVID-19 based on mRNA

Developing and evaluating in preclinical studies a new vaccine based on mRNA against SARS-CoV2 capable of inducing long-term immune responses against the virus is the ultimate goal of the research project in which the laboratory led by María José Alonso participates together with the group led by Mabel Loza, both at CiMUS and FIDIS - University of Santiago de Compostela (USC). The objective of the USC laboratories is to produce a synthetic vehicle based on innocuous biomaterials, capable of transporting the mRNA into the target cells and enabling the production of the antigen in the human body.

María José Alonso, on ‘The Power List’ of the most influential researchers in the field of Biopharmaceuticals

Professor Alonso is the only Spanish scientist in this ranking published by the magazine 'The Medicine Maker'. This ranking highlights the career of the 60 most outstanding researchers worldwide in the areas of Small Molecules, Biopharmaceuticals, and Advanced Medicine

Get free access to our paper: “mRNA-activated matrices encoding transcription factors as primers of cell differentiation in tissue engineering”

Publication: Adriana M. Ledo, Ana Senra, Héctor Rilo-Álvarez, Erea Borrajo, Anxo Vidal, María J. Alonso, Marcos García-Fuentes, RNA-activated matrices encoding transcription factors as primers of cell differentiation in tissue engineering, Biomaterials, Vol. 247, July 2020 https://doi.org/10.1016/j.biomaterials.2020.120016. Free Access until May 26